alnylam header

Alnylam Pharmaceuticals

Alnylam is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of patients who have limited or inadequate treatment options.

Project Goal

Our Task: Design & deliver the first phase of office accommodation for a new UK headquarters. A newly branded reception, feature walkway, client meeting facilities and staff breakout area.

Size & Duration

Size: 6,000 sq. ft
Duration: Average 9 weeks

 

Skills & Results

Workplace Consultancy. Interior Design.

Co-ordination of inputs from Brand Consultant, Furniture & AV Specialists.

Design & Build.

alnylam inner

Project Gallery

Get in Touch

If you are planning a new laboratory, refurbishing an existing one or have any questions, we’d love to hear from you.

Email

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

CONNECT WITH US